Skip to main content

Table 1 Patients’ characteristics and prior management

From: Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience

Age median (range)

51 (32–77)

Sex

 

Male

6 (46%)

Female

7 (54%)

ECOG PS

 

0

2 (15%)

1

9 (70%)

2

2 (15%)

Primary location

 

Thorax

4 (31%)

Abdomen

3 (24%)

Pelvis

2 (15%)

Thigh

2 (15%)

Others

2 (15%)

Prior surgery

 

Yes

8 (62%)

No

5 (38%)

Metastatic disease

 

Yes

10 (77%)

No

3 (23%)

Site of metastases

 

Lungs

4 (31%)

Liver

3 (24%)

Bone

2 (15%)

Intra-abdominal

2 (15%)

Kidney

1 (8%)

Disease progression

 

before pazopanib

13 (100%)